当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:232.20亿  总市值:233.46亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,381,650,198.94603,829,040.383,507,911,150.92,312,310,695.98
  收到的税费返还423,280.12423,278.572,907,422.082,755,600.38
  收到其他与经营活动有关的现金106,792,822.4648,234,574.46352,789,344.21226,792,137.3
  经营活动现金流入小计1,488,866,301.52652,486,893.413,863,607,917.192,541,858,433.66
  购买商品、接受劳务支付的现金856,595,638.9492,198,590.081,576,082,330.171,057,292,663.53
  支付给职工以及为职工支付的现金568,693,422.12315,971,121.411,153,821,278.81925,531,974.13
  支付的各项税费71,442,003.2338,498,076.35206,939,887.39135,466,714.45
  支付其他与经营活动有关的现金405,972,953.4202,912,883.28831,041,595.31566,379,433.63
  经营活动现金流出小计1,902,704,017.651,049,580,671.123,767,885,091.682,684,670,785.74
  经营活动产生的现金流量净额-413,837,716.13-397,093,777.7195,722,825.51-142,812,352.08
二、投资活动产生的现金流量:
  收回投资收到的现金3,127,398,450.951,822,875,351.4511,960,221,087.357,580,390,516.79
  取得投资收益收到的现金37,699,529.6120,132,426.6697,832,649.4476,456,772.4
  处置固定资产、无形资产和其他长期资产收回的现金净额3,304,010.28112,034.57562,147.674,289,214.39
  投资活动现金流入小计3,168,401,990.841,843,119,812.6812,058,615,884.467,661,136,503.58
  购建固定资产、无形资产和其他长期资产支付的现金251,850,582.61170,600,959.19529,480,642.08364,136,982.78
  投资支付的现金3,437,191,534.051,894,099,219.4611,843,551,048.017,824,082,496.95
  支付其他与投资活动有关的现金12,001,775.73---
  投资活动现金流出小计3,701,043,892.392,064,700,178.6512,373,031,690.098,188,219,479.73
  投资活动产生的现金流量净额-532,641,901.55-221,580,365.97-314,415,805.63-527,082,976.15
三、筹资活动产生的现金流量:
  取得借款收到的现金570,960,000570,960,000192,796,406.9161,376,240.15
  收到其他与筹资活动有关的现金69,200,215-53,078,767.553,078,767.5
  筹资活动现金流入小计640,160,215570,960,000245,875,174.4214,455,007.65
  偿还债务支付的现金224,963,873.187,585,692.7337,730,696.5422,792,473.46
  分配股利、利润或偿付利息支付的现金8,573,749.142,881,529.1453,544,931.4450,834,608.28
  其中:子公司支付给少数股东的股利、利润--3,181,5003,181,500
  支付其他与筹资活动有关的现金19,449,739.5911,222,169.46837,751,898.37457,640,013.93
  筹资活动现金流出小计252,987,361.9121,689,391.33929,027,526.35531,267,095.67
  筹资活动产生的现金流量净额387,172,853.09549,270,608.67-683,152,351.95-316,812,088.02
四、汇率变动对现金及现金等价物的影响11,951,421.831,140,128.545,121,479.4919,769,275.45
五、现金及现金等价物净增加额-547,355,342.76-68,263,406.51-856,723,852.58-966,938,140.8
  加:期初现金及现金等价物余额2,698,417,224.42,698,417,224.43,555,141,076.983,555,141,076.98
  期末现金及现金等价物余额2,151,061,881.642,630,153,817.892,698,417,224.42,588,202,936.18
补充资料:
  净利润4,144,746.19--912,101,083.16-
  资产减值准备123,902,940.59-438,444,688.41-
  固定资产和投资性房地产折旧185,266,494.73-362,164,765.23-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧185,266,494.73-362,164,765.23-
  无形资产摊销34,315,001.67-67,701,502.82-
  长期待摊费用摊销21,560,556.68-63,033,131.31-
  处置固定资产、无形资产和其他长期资产的损失1,785,189.01-631,684.81-
  固定资产报废损失2,645,775.93-5,686,770.66-
  公允价值变动损失-9,210,174.71-33,175,650.35-
  财务费用9,285,559.84--10,116,817.26-
  投资损失-18,665,756.39-43,626,260.23-
  递延所得税-50,545,313.11-22,868,842.15-
  其中:递延所得税资产减少-38,588,539.49-11,109,403.54-
    递延所得税负债增加-11,956,773.62-11,759,438.61-
  存货的减少50,000,311.05--34,200,452.89-
  经营性应收项目的减少-336,509,883.07--438,842,458.36-
  经营性应付项目的增加-450,216,467.1-284,489,065.92-
  其他--115,499,013.36-
  不涉及现金收支的投资和筹资活动金额其他项目52,537,066.4-15,402,331.25-
  现金的期末余额2,151,061,881.64-2,698,417,224.4-
  减:现金的期初余额2,698,417,224.4-3,555,141,076.98-
  现金及现金等价物的净增加额-547,355,342.76--856,723,852.58-
公告日期2025-08-232025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑